Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-24

Clinical Trial Update: Staccato Loxapine in Migraine (Out Patient) [Phase 2]

View source ↗

Summary

This document reports a completed Phase 2 outpatient trial of Staccato Loxapine for migraine. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Staccato Loxapine (loxapine)

Snippet

Sponsor: Alexza Pharmaceuticals, Inc. | Conditions: Migraine Headache | Phase 2 | Status: COMPLETED | Results posted: 2017-04-24